Summary: A new preclinical study from Northwestern University identifies a structural explanation for why women are disproportionately affected by Alzheimer’s disease (AD). Rather than focusing solely on neurons and glial cells, researchers examined the extracellular matrix (ECM) — the non-cellular “mortar” that fills spaces between brain cells — and found that aging combined with loss of brain-derived estrogen impairs this scaffold in the female hippocampus, undermining memory support.
Key Facts
- Women bear a heavier AD burden: Nearly two-thirds of Americans living with Alzheimer’s are women. Although post-menopausal estrogen decline has been suspected, the biological mechanisms linking estrogen loss to increased AD risk were unclear.
- The extracellular matrix is essential: The ECM comprises roughly 20% of brain volume and acts like mortar between bricks, creating a molecular network in the hippocampus that supports communication and function of neurons and glial cells.
- Estrogen shifts after menopause: Before menopause, ovaries supply the majority of estrogen. After menopause systemic estrogen drops and the brain must rely on local estrogen synthesis. Evidence suggests this local supply is especially reduced in women with AD.
- Targeted experimental approach: Using genetically engineered mice lacking aromatase — the enzyme required to produce estrogen — researchers isolated the effects of brain-specific estrogen loss from whole-body loss and from aging, and found old females uniquely vulnerable to ECM degradation.
- Limits of anti-amyloid therapies: Current AD drugs that clear amyloid plaques do not directly address the brain’s structural environment. Removing plaques may not restore the degraded ECM that supports memory circuits.
- A new therapeutic direction: The authors propose shifting some focus toward repairing or preserving the extracellular matrix and exploring safer, targeted hormone replacement strategies to protect the female brain before memory loss becomes irreversible.
Source: Northwestern University
A largely overlooked space between brain cells may explain why post-menopausal estrogen loss coincides with increased memory decline in women, according to new preclinical research.
Investigators compared young and old male and female mice with and without brain-specific estrogen production. Their experiments show a specific interaction among aging, female sex, and brain-derived estrogen loss that leads to widespread ECM changes in the hippocampus — a region central to learning and memory. These structural changes correlated with impaired spatial memory, altered social behavior and mood-like symptoms in older female mice.
“Our results indicate that older females — but not males — are uniquely sensitive to loss of brain estrogen, which can destabilize the hippocampal extracellular matrix and contribute to Alzheimer’s-like memory deficits,” said corresponding author Dr. Hong Zhao, research professor at Northwestern University Feinberg School of Medicine.
Published in the journal Aging Cell, the study links local estrogen deficiency to sex- and age-dependent gene expression changes in ECM-related pathways, offering a fresh framework for understanding female vulnerability to AD.
Looking in the space between cells
The extracellular matrix is a complex mesh of proteins and signaling molecules that fills intercellular space. It supports synaptic stability, guides cell-to-cell communication, and helps maintain proper plasticity for learning and memory. Despite these crucial roles, research has historically emphasized neurons and glial cells while paying less attention to ECM integrity. This study is among the first to examine how estrogen loss specifically alters ECM composition and function in the aging female hippocampus.
Bulk RNA sequencing of hippocampal tissue revealed that old females with brain-specific aromatase loss show upregulation of genes tied to ECM remodeling. Several ECM-associated transcripts and proteins (for example, collagen and proteoglycan-related genes) were altered in a pattern consistent with breakdown and disorganization of the matrix scaffold.
New treatment approach focused on the ECM?
Current therapies that reduce amyloid accumulation may address one hallmark of AD but do not repair the extracellular environment that supports neurons. The Northwestern team suggests that interventions aimed at preserving or restoring ECM structure — potentially combined with carefully timed, targeted hormone therapies — could protect memory circuits in women at risk for AD and complement existing treatments.
Estrogen production before and after menopause
Before menopause, ovarian estrogen circulates systemically and helps regulate brain function. After menopause circulating estrogen levels drop sharply; the brain and other tissues produce only small, localized amounts. In rodents, brain-derived estrogen is particularly important in females. Prior observations that women with Alzheimer’s sometimes have lower brain estrogen levels are supported by these new experimental findings.
How does hormone replacement therapy factor in?
Hormone replacement therapy (HRT) has been evaluated as a preventive or therapeutic approach for cognitive decline, but clinical results have been mixed. Differences in timing, hormone formulation, dosage and the age at treatment onset likely contribute to variable outcomes. The new study underscores the need for more refined strategies — possibly targeting local brain estrogen pathways or timing HRT to preserve ECM integrity before irreversible damage occurs.
How the study was conducted
Researchers used two genetically modified mouse models: brain-specific aromatase knockout (bArKO) mice and whole-body aromatase knockout (tArKO) mice, across young (6–8 months) and old (>19 months) age groups of both sexes. Behavioral tests evaluated spatial working memory, social interaction and affective behaviors. The team also performed transcriptomic (RNA-seq) analyses of hippocampal tissue to identify gene expression changes associated with estrogen loss. Behavioral impairments and ECM-related gene alterations were most pronounced in older female mice lacking brain-derived estrogen.
Key questions answered
Why does the space between brain cells matter for memory? Neurons rely on the extracellular matrix as physical and biochemical support. When that scaffold degrades, synaptic connections destabilize and memory processes fail.
Why are women at higher risk for Alzheimer’s? The study suggests a combined effect of sex, age and brain estrogen decline: the female hippocampal ECM appears hyper-dependent on locally produced estrogen, and its loss with age can precipitate structural breakdown that increases vulnerability to AD.
Why aren’t amyloid-clearing drugs fully curative? Removing amyloid plaques does not automatically restore the brain’s structural environment. Effective, lasting recovery likely requires rebuilding or stabilizing the ECM in addition to clearing harmful protein aggregates.
Editorial notes
- This article has been edited for clarity and context.
- The underlying journal paper was reviewed in full and its main findings summarized here.
- Additional explanatory context was added to highlight implications for female brain health and potential therapeutic directions.
About this menopause and dementia research news
Author: Kristin Samuelson
Source: Northwestern University
Contact: Kristin Samuelson – Northwestern University
Image credit: Neuroscience News
Original Research: Open access. “Loss of brain-derived estrogen is associated with sex- and age-dependent alterations in memory, affective behavior, and hippocampal extracellular matrix gene expression.” Study authors include Natalie C. Piehl, Ariel W. Halle, Guadalupe Rodriguez, Andrea Locci, Stacy Kujawa, Caroline Haywood, John Coon V, Ross P. McNally, Zaina A. Karim, Tianming You, Hongxin Dong, Serdar E. Bulun, Hong Zhao. DOI and full citation available in the journal Aging Cell.
Abstract
Loss of brain-derived estrogen is associated with sex- and age-dependent alterations in memory, affective behavior, and hippocampal extracellular matrix gene expression
Nearly two-thirds of Americans with Alzheimer’s disease are women. Prior work has suggested that women with AD may have lower brain estrogen than women without AD, but the mechanisms linking estrogen deficiency to sex-specific vulnerability were not fully defined. Aromatase, the enzyme that synthesizes estrogen, is present in neurons and astrocytes, including in the hippocampus.
This study used brain-specific aromatase knockout (bArKO) and total aromatase knockout (tArKO) mice of both sexes at young (6–8 months) and old (>19 months) ages to evaluate how brain-selective estrogen deficiency influences behavior and hippocampal gene expression. Brain aromatase deletion reduced local estrogen in bArKO mice, while tArKO mice showed reduced circulating and brain estrogen. Behavioral deficits in spatial working memory and social interaction emerged only in old female bArKO and tArKO mice. Depression-like behaviors appeared in both young and old female tArKO mice but not in males.
Transcriptomic analysis of hippocampal tissue revealed enrichment of extracellular matrix-related pathways and increased expression of ECM-associated genes (such as Col1a1, Ccn2, Dcn, and Ogn) in old female bArKO mice compared with controls. These results link local brain estrogen deficiency to sex- and age-specific ECM alterations in the hippocampus that accompany memory and behavioral impairments relevant to Alzheimer’s disease risk in females.